Randomized trial comparing protracted infusion of 5-fluorouracil with weekly doxorubicin and cyclophosphamide with a monthly bolus FAC regimen in metastatic breast carcinoma (SPM90).

Infusional 5-fluorouracil in advanced breast cancer has been associated with improved clinical response rates when compared with conventional bolus therapy. As a first line of chemotherapy in proven metastatic breast carcinoma, 258 women were randomly assigned to receive FAC consisting of 5-fluorour...

Descripción completa

Detalles Bibliográficos
Autores principales: Pierga, J. Y., Jouve, M., Asselain, B., Livartowski, A., Beuzeboc, P., Diéras, V., Scholl, S., Dorval, T., Palangié, T., Garcia-Giralt, E., Pouillart, P.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150182/
https://www.ncbi.nlm.nih.gov/pubmed/9652764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150182/
https://www.ncbi.nlm.nih.gov/pubmed/9652764

Ejemplares similares